- Home
- PGEN vs ACB Comparison
PGEN vs ACB Comparison
Compare PGEN & ACB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PGEN
- ACB
- Stock Information
- Founded
- PGEN 1998
- ACB 2013
- Country
- PGEN United States
- ACB Canada
- Employees
- PGEN N/A
- ACB N/A
- Industry
- PGEN Biotechnology: Pharmaceutical Preparations
- ACB Pharmaceuticals and Biotechnology
- Sector
- PGEN Health Care
- ACB Health Care
- Exchange
- PGEN Nasdaq
- ACB Nasdaq
- Market Cap
- PGEN 292.6M
- ACB 255.7M
- IPO Year
- PGEN N/A
- ACB N/A
- Fundamental
- Price
- PGEN $0.90
- ACB $4.30
- Analyst Decision
- PGEN Buy
- ACB Hold
- Analyst Count
- PGEN 5
- ACB 1
- Target Price
- PGEN $7.00
- ACB N/A
- AVG Volume (30 Days)
- PGEN 858.0K
- ACB 1.3M
- Earning Date
- PGEN 11-14-2024
- ACB 11-06-2024
- Dividend Yield
- PGEN N/A
- ACB N/A
- EPS Growth
- PGEN N/A
- ACB N/A
- EPS
- PGEN N/A
- ACB N/A
- Revenue
- PGEN $3,963,000.00
- ACB $219,835,671.00
- Revenue This Year
- PGEN N/A
- ACB $14.04
- Revenue Next Year
- PGEN $211.35
- ACB $8.94
- P/E Ratio
- PGEN N/A
- ACB N/A
- Revenue Growth
- PGEN N/A
- ACB 13.15
- 52 Week Low
- PGEN $0.77
- ACB $2.84
- 52 Week High
- PGEN $1.93
- ACB $9.35
- Technical
- Relative Strength Index (RSI)
- PGEN 52.02
- ACB 32.99
- Support Level
- PGEN $0.77
- ACB $4.11
- Resistance Level
- PGEN $1.05
- ACB $5.01
- Average True Range (ATR)
- PGEN 0.07
- ACB 0.31
- MACD
- PGEN -0.00
- ACB -0.09
- Stochastic Oscillator
- PGEN 47.46
- ACB 9.31
About PGEN Precigen Inc.
Precigen Inc is a biotechnology company that develops synthetic biology solutions. The company designs build and regulate gene programs. Its technologies are broadly applicable across a wide range of diverse end markets. Intrexon's business model is to commercialize its technologies through exclusive channel collaborations with collaborators that have specific industry expertise, development resources, and sales and marketing capabilities, in order to bring new and improved products and processes to market. Its reportable segments are Biopharmaceuticals and Exemplar. The company's collaborators provide compensation through technology access fees, royalties, milestones, and reimbursement of certain costs.
About ACB Aurora Cannabis Inc.
Aurora Cannabis, headquartered in Edmonton, Canada, cultivates and sells medicinal and recreational cannabis through a portfolio of brands that includes Drift, San Rafael '71, Daily Special, Whistler, Being, and Greybeard. Although the company primarily operates in Canada, it has expanded internationally through medical cannabis exporting agreements.